Gemini bioproducts:1110293 [18-000951] benchmark fetal bovine serum - lot A03G - period of performance 12/05/2017 - 12/04/18

Ended Awarded Last action

Contract number
HHSN26400004
Awardee
Awarding agency
Obligated
$23,299

Award facts

Contract value 100% obligated
$23,299.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Broderick, CA 95605, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$0
Funding Only Action P00001 -$120
Original award $23,419

Quick answers

Who was awarded contract HHSN26400004?

HHSN26400004 was awarded to Gemini Bioproducts LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on December 5, 2017.

How much is contract HHSN26400004 worth?

The government has obligated $23,299 on HHSN26400004.

Is contract HHSN26400004 an order under another contract?

Yes. HHSN26400004 is a BPA call under HHSN263201500189B, a blanket purchase agreement.

Was contract HHSN26400004 competed?

The extent of competition for HHSN26400004 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award